VIDEO: Antibody-drug conjugates show promise in gynecologic cancers
In this video, Robert DeBernardo, MD, shares insight on antibody-drug conjugates as treatment for patients with cancer, a topic discussed at Society of Gynecologic Oncology Annual Meeting on Women’s Cancer.
“We have five antibody-drug conjugates that are FDA-approved, three of which are for gynecologic cancers, and they have been very helpful,” DeBernardo, section head of the department of obstetrics and gynecology and Women’s Health Institute at Cleveland Clinic, said. “This is a concept where we take an antibody to a target on the tumor and then attach a drug to it, a chemotherapy. They’re very specific to the tumor.”
Collapse
Read more about